Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Her2 Fnr'

Her2 Fnr published presentations and documents on DocSlides.

Translating NGS Data into a Clinically Actionable Assay

Translating NGS Data into a Clinically Actionable Assay

  • danika-pritchard
  • 41 Slides

Elaine R. Mardis, Ph.D.. Professor of Genetics. C...

Evaluation of HR[ER/

Evaluation of HR[ER/

  • debby-jeon
  • 60 Slides

PgR. ] status and correlation with Ki67 expres...

Chemotherapeutic Treatment Options for Triple Negative Brea

Chemotherapeutic Treatment Options for Triple Negative Brea

  • lois-ondreau
  • 31 Slides

Lauren Barney. April 17, 2013. Breast Cancer Subt...

New Therapies for Metastatic Breast Cancer

New Therapies for Metastatic Breast Cancer

  • alexa-scheidler
  • 70 Slides

Sigrun Hallmeyer, MD. Oncology Specialists, SC. D...

RESEARCHARTICLEOpenAccess

RESEARCHARTICLEOpenAccess

  • alida-meadow
  • 100 Slides

Proposednewclinicopathologicalsurrogate definition...

At the Forefront of Immunotherapy

At the Forefront of Immunotherapy

  • karlyn-bohler
  • 20 Slides

OTCQB: TPIV. 1551 Eastlake Ave E. Suite 100. Seat...

Breast Cancer Highlights From San Antonio

Breast Cancer Highlights From San Antonio

  • tatyana-admore
  • 99 Slides

Joyce O'Shaughnessy, MD. Kimberly Blackwell, MD. ...

Chemotherapeutic Treatment Options for Triple Negative Brea

Chemotherapeutic Treatment Options for Triple Negative Brea

  • alida-meadow
  • 30 Slides

Lauren Barney. April 17, 2013. Breast Cancer Subt...

Metastatic Breast Cancer

Metastatic Breast Cancer

  • lindy-dunigan
  • 36 Slides

A sub-focus on specific clinical scenarios. What ...

update in metastatic breast c

update in metastatic breast c

  • min-jolicoeur
  • 27 Slides

. Dr.Mina. . Tajvidi. Radiation . oncologist. ...

RCR breast radiotherapy consensus guidelines

RCR breast radiotherapy consensus guidelines

  • karlyn-bohler
  • 9 Slides

Producing the guidelines. Draft radiotherapy guid...

Evaluation of HR[ER/ PgR

Evaluation of HR[ER/ PgR

  • pasty-toler
  • 0 Slides

] status and correlation with Ki67 expression ...

Genomic/Genetic Testing Germline v Somatic testing and the importance of Molecular Tumor Boards

Genomic/Genetic Testing Germline v Somatic testing and the importance of Molecular Tumor Boards

  • lois-ondreau
  • 0 Slides

Ben Ho Park MD PhD. Johns Hopkins University. Fin...

update in metastatic breast cancer

update in metastatic breast cancer

  • calandra-battersby
  • 0 Slides

. Dr.Mina. . Tajvidi. Radiation . oncologist. ...

Neoadjuvant Target Therapy in Her-2 Positive Breast Cancer

Neoadjuvant Target Therapy in Her-2 Positive Breast Cancer

  • faustina-dinatale
  • 0 Slides

Dr. . Khaled Abulkhair, PhD. Medical Oncology SCE...

CDK 4/6 Inhibitors in Breast Cancer Expert Perspectives on New Data

CDK 4/6 Inhibitors in Breast Cancer Expert Perspectives on New Data

  • min-jolicoeur
  • 22 Slides

CDK 4/6 Inhibitors in Breast Cance...

Endocrine Treatment of Metastatic Breast Cancer: New Advances; Patient Education Implications

Endocrine Treatment of Metastatic Breast Cancer: New Advances; Patient Education Implications

  • calandra-battersby
  • 74 Slides

An Interactive Oncology Grand Rounds Series. Joyc...

Moving Evidence into Practice: Breast Cancer Highlights From Chicago

Moving Evidence into Practice: Breast Cancer Highlights From Chicago

  • alida-meadow
  • 28 Slides

This program will include a discussion of off-lab...

Brea st cancer G eneral

Brea st cancer G eneral

  • slayrboot
  • 89 Slides

. in. f. orma. t. ion. Risk. . f. a. ct. ors. Pro...

A case of localized breast cancer

A case of localized breast cancer

  • envrrolex
  • 21 Slides

Antonella Brunello . Kwok-Leung Cheung. Disclosure...

Eribulin Mesylate + Trastuzumab

Eribulin Mesylate + Trastuzumab

  • easyho
  • 10 Slides

as First-Line Therapy for Locally Recurrent or . M...

TARGETED CANCER THERAPY IN 2016:

TARGETED CANCER THERAPY IN 2016:

  • bagony
  • 14 Slides

WHAT THE PRACTICING PATHOLOGIST OR ONCOLOGIST NEED...

KER/DAPI KER DAPI CD45 HER2

KER/DAPI KER DAPI CD45 HER2

  • projoutr
  • 1 Slides

A. B. C. D. 0. 1+. 2+. 3+. 3+. 3+. 3+.

20 March 2014EMACHMP1518532014Committee for Medicinal Products for

20 March 2014EMACHMP1518532014Committee for Medicinal Products for

  • nicole
  • 3 Slides

Adoptedby CHMPfor release for consultation20 March...

Best practice for chemotherapy for treatment of breast cancer

Best practice for chemotherapy for treatment of breast cancer

  • ariel
  • 42 Slides

Andreas Makris. Mount Vernon Cancer Center. Royal ...

Dawid Sigorski, Ph.D .

Dawid Sigorski, Ph.D .

  • morgan
  • 65 Slides

Department. of . oncology. . UWM. Epidemiology. ...

Chemotherapeutic Treatment Options for Triple Negative Breast Cancer

Chemotherapeutic Treatment Options for Triple Negative Breast Cancer

  • iris
  • 30 Slides

Lauren Barney. April 17, 2013. Breast Cancer Subty...

Breast Cancer in Older Patients

Breast Cancer in Older Patients

  • ButterflyKisses
  • 51 Slides

Key Issues. Etienne GC . Brain. , MD . PhD. Instit...

Immunotherapy of Breast Cancer

Immunotherapy of Breast Cancer

  • WhereTheWildThingsAre
  • 27 Slides

World Congress on Breast Cancer . ...

Use specific response toward environment as a selective marker for therapy in breast cancer cells.

Use specific response toward environment as a selective marker for therapy in breast cancer cells.

  • BraveButterfly
  • 26 Slides

Hsiu. -Ni Kung. Anatomy and Cell Biology, Medical ...

Pathology of The Breast Lesions of female breast are much more common than lesions of male breast

Pathology of The Breast Lesions of female breast are much more common than lesions of male breast

  • PrincessPeach
  • 33 Slides

Most of these lesions are benign. Breast cancer i...

Understanding Your Diagnosis29 Not all breast cancers are the same

Understanding Your Diagnosis29 Not all breast cancers are the same

  • adia
  • 7 Slides

ere are two separate ideas used when describi...

x0000x0000 xMCIxD 0 xMCIxD 0 xMCIxD 1

x0000x0000 xMCIxD 0 xMCIxD 0 xMCIxD 1

  • payton
  • 9 Slides

ENHERTUSignificantlyImproved Both ProgressionFree ...

Oncological perspective on Invasive lobular carcinoma

Oncological perspective on Invasive lobular carcinoma

  • elise
  • 20 Slides

Anne Sofie Brems-Eskildsen. Department of Oncology...

THBT neoadjuvant endocrine

THBT neoadjuvant endocrine

  • lucinda
  • 28 Slides

therapy. . is. to be . used. in post-. menopaus...

Adjuvant Therapy For Breast Cancer

Adjuvant Therapy For Breast Cancer

  • eddey
  • 46 Slides

. Breast Cancer | . Epidemiology- Australia. Austr...

SWAG guidelines Mark Beresford

SWAG guidelines Mark Beresford

  • natalie
  • 9 Slides

Oncotype. DX testing in network. Node negative â€...

Cutoff value for prominent biomarkers of breast cancer on overall survival using CART analysis

Cutoff value for prominent biomarkers of breast cancer on overall survival using CART analysis

  • eddey
  • 4 Slides

Pragya Kumari. 1. , . Atanu. Bhattacharjee. 2. , ...

Predictive marker update &

Predictive marker update &

  • ella
  • 35 Slides

multiparameter. molecular markers. September 25, ...

Module 8: ER-Positive Metastatic

Module 8: ER-Positive Metastatic

  • anastasia
  • 50 Slides

Breast Cancer . Elizabeth O’Reilly, MSN, MPH, AN...

Copyright © 2024 DocSlides. All Rights Reserved